Carregando...
Synergistic drug combinations and machine learning for drug repurposing in chordoma
Chordoma is a devastating rare cancer that affects one in a million people. With a mean-survival of just 6 years and no approved medicines, the primary treatments are surgery and radiation. In order to speed new medicines to chordoma patients, a drug repurposing strategy represents an attractive app...
Na minha lista:
| Publicado no: | Sci Rep |
|---|---|
| Principais autores: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395084/ https://ncbi.nlm.nih.gov/pubmed/32737414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-70026-w |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|